Patent ID: 9173939
Filing Date: 2015-11-03
Classification: A61K,A61P,C07C

Abstract:
1. A compound having the following structure (Ic): or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein: R R R wherein, halo is selected from the group consisting of F, Br, and I; R R R R n wherein at least one of R 1 , R 2 , or R 3 is —OC(═O)R 13 ; wherein R 3 is not —OC(═O)CH 3 when R 1 and R 2 are both hydroxyl; wherein R 1 and R 2 are not both —OC(═O)CH═CH 2 ; and wherein R 1 and R 2 are not both —OC(═O)C(CH 1 )═CH 2 .